Mikra in development for an innovative product aimed at supporting mental health

TORONTO, September 26, 2023– Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to provide a corporate update for its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”) including the development of a new and proprietary supplement aimed at supporting the mental health issue of anxiety. Mikra is pushing biosciences beyond the expected with the belief it is possible to add more valuable, enjoyable years to your life through rebuilding and protecting your cellular health.

“We are pleased to share an update on the continued progress of our U.S. biosciences subsidiary, Mikra Cellular Sciences Inc.,” said Meni Morim, CEO of Lifeist. “Mikra’s mission is to enhance vigorous lifespan and well-being by focusing on cellular health. Toward that goal, we have developed a new supplement to help support mental wellness, a pressing global concern. We are building off the success of our flagship product, CELLF which utilizes bioactive compounds to impact various bodily systems, reflecting our commitment to evidence-backed innovation. CELLF’s availability on Amazon marks a significant expansion of distribution channels, with initial sales showing promising growth. We look forward to sharing more details about our new mental health product as we work to finalize the lab formulation in the 4th quarter.”

After the successful launch of CELLF and its improved version CELLF v1.2, a cellular health nutraceutical gel formulated with bioactive compounds to positively impact your brain, heart, skin and muscular systems, Mikra is dedicated to unveiling innovative products that add healthy, active, and high-quality years to one’s life. It is currently in the formulation finalization phase of achieving a proprietary supplement aimed at supporting mental health among those who wrestle with anxiety. This initiative is in direct response to the growing worldwide emphasis on mental well-being and the “quiet epidemic” of anxiety among young adults, caused by the unprecedented pressures of life in the 21st century which have brought mental health to the forefront.1 Mikra is committed to leading the way in exploring natural supplements to help support our customers in their journey, without the adverse side effects of harsh and habit-forming pharmaceutical interventions.

Earlier this year marked the official debut of Mikra’s nutraceutical products for purchase on Mikra’s Amazon storefront. The availability of Mikra’s first two products on the leading e-commerce site marks a significant advancement in distribution for Mikra’s products, which until now have been available for sale exclusively through its direct-to-consumer website, wearemikra.com. Consumers can purchase CELLF on Amazon in the United States and RESCUE in both the United States and Canada with both products eligible for Amazon Prime free shipping benefits.

Mikra is also working closely with major partners to refine marketing strategies, packaging, and display designs, with the future goal of making a more significant impact in both online and retail stores.

1 Population Mental Health in the 21st Century: Time to Act – PMC (nih.gov)

About Lifeist Wellness Inc.

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; Australian Vapes, one of Australia’s largest online retailers of vaporizers and accessories; and Mikra, a biosciences and consumer wellness company developing and selling innovative therapies for cellular health.